From £6.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

BOMBSHELL EXPOSE: Roquefort Thereapeutics – more red flags than a May day Parade in Moscow

By Tom Winnifrith | Friday 12 May 2023


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


Roquefort (ROQ) was a Standard List shell brought to market by the scumbags at Optiva as s shell in March 2021, raising a Bernie at 5p - I did warn folks about it HERE. Its shares are now suspended at 6.75p as it could not get its accounts out on time. But the history of the main player, CEO Ajan Reginald should be telling you that this is a monumental bargepole and everyone involved, from the FCA downwards should be highly concerned.
Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

HAT

H&T Group – now again a Buy

Time left: 07:06:09